CHAIRMAN OF THE COMMITTEE
Pavel Khegay, Director of the Representative Office of JSC Gedeon Richter in the Republic of Kazakhstan / General Director of LLP Gedeon Richter KZ.
Tel: +7 (727) 258-26-23. E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
COMMITTEE MEMBERS
Dmitry Kozenkov – Director of the Branch Pfizer Export B.V. in Kazakhstan
Oleg Negulyaev – General Director of LLP Servier Kazakhstan
Elmira Bimakhanova – Head of the Representative Office WOERWAG PHARMA GmbH & Co. KG in Kazakhstan.
WORKING GROUP MEMBERS
Assiya Maksutova, Head of the Working Group on Amendments to the AMFP Ethical Code, LLP Takeda Kazakhstan
Tel.: +7 (727) 244 40 04
Mob.: +7 771 501 77 67
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
Tatyana Zhaubasarova, Branch of LLC Johnson & Johnson in the Republic of Kazakhstan
Mob.: +7 701 523 98 51
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
Assel Serikopova, Head of Regulatory Compliance in Kazakhstan, the Caucasus and Central Asia, Sandoz
Tel.: +7 701 757 57 93
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
Artem Tukach, Medical Manager, Ipsen
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
Elena Nazarova, Compliance Manager, Pfizer in the Republic of Kazakhstan
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
REGULATIONS ON THE ETHICS COMMITTEE
The Ethics Committee has been established to ensure the coordination and control of AIPM members’ activities aimed at adhering to the ethical principles of marketing practices adopted in the research-based pharmaceutical industry.
The competence of the Ethics Committee includes:
-
Reviewing statements and resolving issues and problems related to improper compliance with the ethical standards and rules of this Code;
-
Electing the Chair of the Ethics Committee (from among members elected by the General Assembly of AIPM members) and terminating his/her powers.
The Ethics Committee shall consist of no fewer than five persons.
Members of the Ethics Committee are elected by the General Assembly of AIPM until the next annual General Assembly, by a simple majority of votes of the members present.
Individuals elected to the Ethics Committee may be re-elected an unlimited number of times.
The President and members of the AIPM Board may not be elected to the Ethics Committee.
Meetings of the Ethics Committee may be convened by the Chair at his/her own initiative, at the initiative of a Committee member, or upon receipt of a complaint from any company regarding improper compliance with the provisions of the Code.
